Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: SYK

Stryker Corporation

Healthcare | Medical - Devices
$326.54 -0.97 (-0.30%) as of 2026-07-14 13:08 UTC
Volume2.60M
EPS (TTM)$8.40

Stryker Corporation (NYSE: SYK) is a medical - devices company trading at $326.54 (−0.3% today) — 38.9× trailing earnings, yielding 1.02%. Figures from SEC EDGAR and market feeds; updated 2026-07-14 13:08 UTC.

52-Week Range
Low $307.49High $404.87

What Stryker Corporation does

Stryker Corporation is a global medical technology company incorporated in Michigan in 1946 that develops and sells products across two main business segments: MedSurg and Neurotechnology, and Orthopaedics. The company offers surgical equipment, endoscopic systems, patient handling products, stroke treatment devices, and orthopedic implants, among other medical products. Stryker sells its products in approximately 61 countries through company-owned operations and third-party distributors, primarily to doctors, hospitals, and healthcare facilities.

Summarized from Stryker Corporation’s SEC filings · Read the filing ↗

Key facts
Quote
Price$326.54
Change (1D)-0.97 (-0.30%)
Volume2.60M shares
52-week range$307.49 – $404.87
Valuation
P/E (TTM)38.87×
EPS (TTM)$8.40
Dividend yield1.02%
Return on equity14.48%
Debt/equity0.71
Returns
52-week return+6.2%
Revenue, margins & earnings
FY2021 Net income: $1.99BFY2021 Taxes & interest: $590MFY2021 Operating expenses: $8.38BFY2021 Cost of revenue: $6.14B$17.1BFY2021FY2022 Net income: $2.36BFY2022 Taxes & interest: $483MFY2022 Operating expenses: $8.74BFY2022 Cost of revenue: $6.87B$18.4BFY2022FY2023 Net income: $3.17BFY2023 Taxes & interest: $723MFY2023 Operating expenses: $9.17BFY2023 Cost of revenue: $7.44B$20.5BFY2023FY2024 Net income: $2.99BFY2024 Taxes & interest: $696MFY2024 Operating expenses: $10.8BFY2024 Cost of revenue: $8.15B$22.6BFY2024FY2025 Net income: $3.25BFY2025 Taxes & interest: $1.64BFY2025 Operating expenses: $11.2BFY2025 Cost of revenue: $9.05B$25.1BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-02
  • 2026-06-02Stiles Spencer SPresident and COOG-1,607—
  • 2026-05-29Fletcher Robert SVP, Chief Legal OfficerSELL-165$50.4K
  • 2026-05-29Fletcher Robert SVP, Chief Legal OfficerSELL-120$36.5K
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC33,906,640$11.92B+0.4%
  • BlackRock, Inc.26,746,191$8.79B-2.6%
  • VANGUARD CAPITAL MANAGEMENT LLC22,383,181$7.35BNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Stryker Corporation do?

Stryker Corporation is a global medical technology company incorporated in Michigan in 1946 that develops and sells products across two main business segments: MedSurg and Neurotechnology, and Orthopaedics.

What is SYK's valuation?

SYK trades at $326.54, 38.87× trailing earnings, as of 2026-07-14. It carries a 1.02% dividend yield.

When did SYK last file with the SEC?

Stryker Corporation's most recent SEC filing on record is a 10-Q filed 2026-05-11. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 13:08 UTC. This page is also available as JSON at /api/data?ticker=SYK and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for SYK and 3,500+ tickers.

Create a free account — keep SYK
For your agent
GET /api/data?ticker=SYK

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt